Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes.
<p>Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes.</p>
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1852016605401186304 |
|---|---|
| author | Milan Dusik (18391630) |
| author2 | Stepan Havranek (2588023) Daniel Rob (3344015) Jan Simek (2588032) Martin Valek (22250603) Zdenka Fingrova (2588014) Tomas Boucek (22250606) Jan Pudil (8822528) Ales Linhart (695297) Jan Belohlavek (695300) |
| author2_role | author author author author author author author author author |
| author_facet | Milan Dusik (18391630) Stepan Havranek (2588023) Daniel Rob (3344015) Jan Simek (2588032) Martin Valek (22250603) Zdenka Fingrova (2588014) Tomas Boucek (22250606) Jan Pudil (8822528) Ales Linhart (695297) Jan Belohlavek (695300) |
| author_role | author |
| dc.creator.none.fl_str_mv | Milan Dusik (18391630) Stepan Havranek (2588023) Daniel Rob (3344015) Jan Simek (2588032) Martin Valek (22250603) Zdenka Fingrova (2588014) Tomas Boucek (22250606) Jan Pudil (8822528) Ales Linhart (695297) Jan Belohlavek (695300) |
| dc.date.none.fl_str_mv | 2025-09-15T17:32:21Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0332597.t003 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Patients_ablated_for_supraventricular_tachycardias_MCS_and_ablation_details_and_outcomes_/30130112 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Medicine Microbiology Cell Biology Ecology Developmental Biology Marine Biology Science Policy Hematology Infectious Diseases Biological Sciences not elsewhere classified xlink "> short severe cardiogenic shock mechanical circulatory supports focal atrial tachycardia ablate strategy ). 2x impella cp hemodynamically significant arrhythmias 1x va ecmo 1x impella 5 identify cs patients catheter ablation may one patient underwent cs patients treated impella cp va ecmo cs ). one patient 5 ). significant complications refractory arrhythmias catheter ablation atrial fibrillation 5 patients patient died 1 patient three patients stabilize patients seven patients nine patients 6 patients 4 patients 3 patients 2 patients ventricular tachycardias treatment resistant successfully weaned successfully explanted retrospectively analysed january 2020 iqr 67 iqr 60 feasible approach dedicated registry august 2024 arrhythmia recurred analysed separately 8 males 66 %). 56 %). 30 days |
| dc.title.none.fl_str_mv | Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes. |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_cfdaebfb1dd8bfa8d6f8fa12bc8acb73 |
| identifier_str_mv | 10.1371/journal.pone.0332597.t003 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30130112 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes.Milan Dusik (18391630)Stepan Havranek (2588023)Daniel Rob (3344015)Jan Simek (2588032)Martin Valek (22250603)Zdenka Fingrova (2588014)Tomas Boucek (22250606)Jan Pudil (8822528)Ales Linhart (695297)Jan Belohlavek (695300)MedicineMicrobiologyCell BiologyEcologyDevelopmental BiologyMarine BiologyScience PolicyHematologyInfectious DiseasesBiological Sciences not elsewhere classifiedxlink "> shortsevere cardiogenic shockmechanical circulatory supportsfocal atrial tachycardiaablate strategy ).2x impella cphemodynamically significant arrhythmias1x va ecmo1x impella 5identify cs patientscatheter ablation mayone patient underwentcs patients treatedimpella cpva ecmocs ).one patient5 ).significant complicationsrefractory arrhythmiascatheter ablationatrial fibrillation5 patientspatient died1 patientthree patientsstabilize patientsseven patientsnine patients6 patients4 patients3 patients2 patientsventricular tachycardiastreatment resistantsuccessfully weanedsuccessfully explantedretrospectively analysedjanuary 2020iqr 67iqr 60feasible approachdedicated registryaugust 2024arrhythmia recurredanalysed separately8 males66 %).56 %).30 days<p>Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes.</p>2025-09-15T17:32:21ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pone.0332597.t003https://figshare.com/articles/dataset/Patients_ablated_for_supraventricular_tachycardias_MCS_and_ablation_details_and_outcomes_/30130112CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/301301122025-09-15T17:32:21Z |
| spellingShingle | Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes. Milan Dusik (18391630) Medicine Microbiology Cell Biology Ecology Developmental Biology Marine Biology Science Policy Hematology Infectious Diseases Biological Sciences not elsewhere classified xlink "> short severe cardiogenic shock mechanical circulatory supports focal atrial tachycardia ablate strategy ). 2x impella cp hemodynamically significant arrhythmias 1x va ecmo 1x impella 5 identify cs patients catheter ablation may one patient underwent cs patients treated impella cp va ecmo cs ). one patient 5 ). significant complications refractory arrhythmias catheter ablation atrial fibrillation 5 patients patient died 1 patient three patients stabilize patients seven patients nine patients 6 patients 4 patients 3 patients 2 patients ventricular tachycardias treatment resistant successfully weaned successfully explanted retrospectively analysed january 2020 iqr 67 iqr 60 feasible approach dedicated registry august 2024 arrhythmia recurred analysed separately 8 males 66 %). 56 %). 30 days |
| status_str | publishedVersion |
| title | Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes. |
| title_full | Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes. |
| title_fullStr | Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes. |
| title_full_unstemmed | Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes. |
| title_short | Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes. |
| title_sort | Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes. |
| topic | Medicine Microbiology Cell Biology Ecology Developmental Biology Marine Biology Science Policy Hematology Infectious Diseases Biological Sciences not elsewhere classified xlink "> short severe cardiogenic shock mechanical circulatory supports focal atrial tachycardia ablate strategy ). 2x impella cp hemodynamically significant arrhythmias 1x va ecmo 1x impella 5 identify cs patients catheter ablation may one patient underwent cs patients treated impella cp va ecmo cs ). one patient 5 ). significant complications refractory arrhythmias catheter ablation atrial fibrillation 5 patients patient died 1 patient three patients stabilize patients seven patients nine patients 6 patients 4 patients 3 patients 2 patients ventricular tachycardias treatment resistant successfully weaned successfully explanted retrospectively analysed january 2020 iqr 67 iqr 60 feasible approach dedicated registry august 2024 arrhythmia recurred analysed separately 8 males 66 %). 56 %). 30 days |